A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients

Complementary Therapies in Medicine

Volumn 13, Issue 3, 2005, Pages 175-182

  Wong, Vincent Wai Sun ^a   Law, Man Yee ^a   Hui, Alex Yui ^a   Lo, Angeline Oi Shan ^a   Li, Cheuk Yin ^a   Soo, Man Tak ^a   Leung, Hor Yee ^a   Chan, Henry Lik Yuen ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABRUS CANTONIENSIS HANCE EXTRACT; AMOMUM VILLOSUM EXTRACT; ASTRAGALUS MONGHOLICUS EXTRACT; ATRACTYLODES EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; BUPLEURUM FALCATUM EXTRACT; CARAPAX AMYDAE EXTRACT; CHINESE DRUG; CITRON EXTRACT; CODONOPSIS PILOSULA EXTRACT; CORDYCEPS SINENSIS EXTRACT; DESMODIUM STYRACIFOLIUM EXTRACT; GANODERMA LUCIDUM EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HEDYOTIS DIFFUSA EXTRACT; HERBACEOUS AGENT; ISATIS TINCTORIA EXTRACT; LIGUSTRUM LUCIDUM EXTRACT; LOBELIA CHINENSIS EXTRACT; LYCIUM CHINENSE EXTRACT; PHYLLANTHUS URINARIA EXTRACT; PLANT EXTRACT; PLECTRANTHUS STRIATUS EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; POLYGONUM MULTIFLORUM EXTRACT; PORIA COCOS EXTRACT; PRUNELLA VULGARIS EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SCHISANDRA CHINENSIS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABRUS; ADULT; AMOMUM; ARTICLE; ASTRAGALUS PLANT; ATRACTYLODES; BUPLEURUM; CARAPAX; CHINA; CHINESE MEDICINE; CITRON; CODONOPSIS; CONTROLLED STUDY; CORDYCEPS; DESMODIUM; DOCTOR PATIENT RELATION; DRUG USE; FAMILY HISTORY; FEMALE; GANODERMA LUCIDUM; GLYCYRRHIZA URALENSIS; HEALTH SURVEY; HEDYOTIS; HEPATITIS B; HERBAL MEDICINE; HONG KONG; HUMAN; ISATIS; LIGUSTRUM; LOBELIA; LYCIUM; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MULTIVARIATE ANALYSIS; PATIENT INFORMATION; PHYLLANTHUS; PLECTRANTHUS; POLYGONUM; POLYGONUM CUSPIDATUM; PORIA; PRUNELLA; QUESTIONNAIRE; SALVIA MILTIORRHIZA; SCHISANDRACEAE; SIDE EFFECT; TRAVEL; UNIVERSITY HOSPITAL;

ADULT; DRUG UTILIZATION; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS C, CHRONIC; HONG KONG; HOSPITALS, TEACHING; HUMANS; INPATIENTS; MALE;

EID: 24344447826     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2005.04.006     Document Type: Article

References (29)

1. I.D. Gust Epidemiology of hepatitis B infection in the Western Pacific and South East Asia Gut 38 Suppl. 2 1996 18-23
2. S.W. Schalm J. Heathcote J. Cianciara et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial Gut 46 2000 562-568
3. C.L. Lai J. Dienstag E. Schiff et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B Clin Infect Dis 36 2003 687-696
4. P. Angus R. Vaughan S. Xiong et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase Gastroenterology 125 2003 292-297
5. C.L. Lai R.N. Chien N.W. Leung et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group N Engl J Med 339 1998 61-68
6. P. Marcellin T.T. Chang S.G. Lim et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B N Engl J Med 348 2003 808-816
7. D.M. Eisenberg R.B. Davis S.L. Ettner et al. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey J Am Med Assoc 280 1998 1569-1575
8. A. Vickers C. Zollman ABC of complementary medicine: Herbal medicine Br Med J 319 1999 1050-1053
9. R.P.L. Lee Perceptions and uses of Chinese medicine among the Chinese in Hong Kong Cult Med Psychiatry 4 1980 345-375
10. Wong TW, Yu TS, Liu JLY, Lee NL, Lloyd OL. Factors associated with the utilization of traditional Chinese medicine in a small town in Hong Kong. Am J Chinese Med 1997;25:367-73.
11. Lau JTF, Leung EMF, Tsui HY. Predicting traditional Chinese medicine's use and the marginalization of medical care in Hong Kong. Am J Chinese Med 2001;29:547-58.
12. A. Fugh-Berman Herb - durg interactions Lancet 355 2000 481-482
13. L.G. Miller Herbal medicinals: Selected clinical considerations focusing on known or potential durg-herb interactions Arch Intern Med 158 1998 2200-2211
14. P. De Smet Drug interactions with herbal and other non-orthodox remedies In: P.F. D'Arcy J.C. McElnay PG. Wellling editors. Mechanisms of drug interactions 1996 Springer Publishing Co. Inc. New York 327-352
15. T.D. Schiano Hepatotoxicity and complementary and alternative medicines Clin Liver Dis 7 2003 453-473
16. C. Stedman Herbal hepatotoxicity Semin Liver Dis 22 2002 195-206
17. D.B. Strader B.R. Bacon K.L. Lindsay et al. Use of complementary and alternative medicine in patients with liver disease Am J Gastroenterol 97 2002 2391-2397
18. Z.C. Yang S. Yang S. Yang D. Chen A hospital-based study on the use of alternative medicine in patients with chronic liver and gastrointestinal diseases Am J Chin Med 30 2002 637-643
19. H.L.Y. Chan Y. Hui N.W.Y. Leung J.Y.L. Ching F.K.L. Chan J.J.Y. Sung Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus (HBV) infected patients Am J Gastroenterol 95 2000 3547-3551
20. D.M. Eisenberg R.C. Kessler C. Foster F.E. Norlock D.R. Calkins T.L. Delbanco Unconventional medicine in the United States. Prevalence, costs, and patterns of use N Engl J Med 328 1993 246-252
21. L. Langmead D.S. Rampton Herbal treatment in gastrointestinal and liver disease - benefits and dangers Aliment Pharmacol Ther 15 2001 1239-1252
22. J.P. Liu H. McIntosh H. Lin Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection Cochrane Database Syst Rev 2 2001 CD002231
23. J.P. Liu H. McIntosh H. Lin Chinese medicinal herbs for chronic hepatitis B Cochrane Database Syst Rev 1 2001 CD001940
24. H.L.Y. Chan J.J.Y. Sung W.F. Fong et al. Double-blinded placebo-controlled study on Phyllanthus urinaris for the treatment of chronic hepatitis B Aliment Pharmacol Ther 18 2003 339-345
25. H. Miyao T. Arao M. Udayama J. Kinjo T. Nohara Kaikasaponin III soyasaponin I, major triterpene saponins of Abrus cantoniensis, act on GOT and GPT: Influence on transaminase elevation of rat liver cells concomitantly exposed to CCl4 for one hour Planta Med 64 1998 5-7
26. G.L. Zhang Y.H. Wang W. Ni H.L. Teng Z.B. Lin Hepatoprotective role of Ganoderma lucidum polysaccharide against BCG-induced immune liver injury in mice World J Gastroenterol 8 2002 728-733
27. D.H. Kim S.B. Shim N.J. Kim I.S. Jang Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum Biol Pharm Bull 22 1999 162-164
28. T.Y.K. Chan J.C.N. Chan Chinese Herbal Medicines revised: A Hong Kong perspective Lancet 342 1993 1532-1534
29. P.P.H. But Herbal poisoning caused by adulterants or erroneous substitutes J Trop Med Hyg 97 1994 371-374